Fig. 2From: Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancerDrug dose response curves for five compounds for ovarian cancer cell line A2780: mitoxantrone, podophyllotoxin, wortmannin, doxorubicin, and 17-AAGBack to article page